Cancer stem cell drugs target K-ras signaling in a stemness context
暂无分享,去创建一个
T Aittokallio | T. Aittokallio | A. Jaiswal | D. Abankwa | I. M. Posada | A K Najumudeen | A Jaiswal | B Lectez | C Oetken-Lindholm | C Guzmán | E Siljamäki | I M D Posada | E Lacey | D Abankwa | B. Lectez | E. Lacey | C. Oetken-Lindholm | E. Siljamäki | A. Najumudeen | C. Guzmán | A. K. Najumudeen
[1] J. Hancock,et al. An N-Terminal Polybasic Motif of Gαq Is Required for Signaling and Influences Membrane Nanodomain Distribution , 2010, Molecular Pharmacology.
[2] Adam A. Margolin,et al. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity , 2018, Nature.
[3] Andrew M. Piggott,et al. Staurosporines Disrupt Phosphatidylserine Trafficking and Mislocalize Ras Proteins* , 2012, The Journal of Biological Chemistry.
[4] Austin G Smith,et al. The Liberation of Embryonic Stem Cells , 2011, PLoS genetics.
[5] The less-often-traveled surface of stem cells: caveolin-1 and caveolae in stem cells, tissue repair and regeneration , 2013, Stem Cell Research & Therapy.
[6] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[7] M. Nykter,et al. ESTOOLS Data@Hand: human stem cell gene expression resource , 2013, Nature Methods.
[8] Tianhai Tian,et al. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction , 2007, Nature Cell Biology.
[9] A. Gorfe,et al. Ras membrane orientation and nanodomain localization generate isoform diversity , 2010, Proceedings of the National Academy of Sciences.
[10] Yong Zhou,et al. Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers. , 2015, Biochemistry.
[11] T. Kipps,et al. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells , 2011, Proceedings of the National Academy of Sciences.
[12] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[13] T. Aittokallio,et al. Figures and figure supplements Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation , 2015 .
[14] Yong Zhou,et al. Ras nanoclusters: Versatile lipid-based signaling platforms. , 2015, Biochimica et biophysica acta.
[15] H. Vogel,et al. A FRET map of membrane anchors suggests distinct microdomains of heterotrimeric G proteins , 2007, Journal of Cell Science.
[16] W. Janzen,et al. High Throughput Screening , 2016, Methods in Molecular Biology.
[17] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[18] Peng Qiu,et al. TCGA-Assembler: open-source software for retrieving and processing TCGA data , 2014, Nature Methods.
[19] Adam Huczyński. Polyether Ionophores‐Promising Bioactive Molecules for Cancer Therapy , 2013 .
[20] J. Hancock,et al. The Effects of Transmembrane Sequence and Dimerization on Cleavage of the p75 Neurotrophin Receptor by γ-Secretase* , 2012, The Journal of Biological Chemistry.
[21] K. Alexandrov,et al. Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins , 2013, PloS one.
[22] S. Hell. Far-field optical nanoscopy , 2010 .
[23] S. Grinstein,et al. High-resolution mapping reveals topologically distinct cellular pools of phosphatidylserine , 2011, The Journal of cell biology.
[24] F. Sotgia,et al. Caveolin-1-Deficient Mice Have An Increased Mammary Stem Cell Population with Upregulation of Wnt/?-Catenin Signaling , 2005, Cell cycle.
[25] Fengfei Wang,et al. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. , 2013, Current medicinal chemistry.
[26] P. Leung,et al. Identification of the Binding and Inhibition Sites in the Calmodulin Molecule for Ophiobolin A by Site-Directed Mutagenesis , 1998 .
[27] S. Cagnol,et al. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer , 2014, Oncogene.
[28] Jing Wang,et al. An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition , 2014, Nature Cell Biology.
[29] A. Balmain,et al. K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling , 2015, Cell.
[30] J Andrew McCammon,et al. A novel switch region regulates H‐ras membrane orientation and signal output , 2008, The EMBO journal.
[31] F. Sotgia,et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. , 2009, The American journal of pathology.
[32] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[33] S. Gygi,et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes , 2009, The Journal of cell biology.
[34] M. Kirkham,et al. Evolutionary analysis and molecular dissection of caveola biogenesis , 2008, Journal of Cell Science.
[35] Melissa J. Davis,et al. Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions? , 2012, Developmental cell.
[36] Adam J. Engler,et al. Matrix elasticity directs stem cell differentiation , 2006 .
[37] Robert G. Parton,et al. Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae , 2011, Cell.
[38] Jan Paul Medema,et al. Cancer stem cells: The challenges ahead , 2013, Nature Cell Biology.
[39] G. Opelz,et al. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.
[40] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[41] J. Settleman,et al. Activated Kras, but Not Hras or Nras, May Initiate Tumors of Endodermal Origin via Stem Cell Expansion , 2008, Molecular and Cellular Biology.
[42] Travis L. Rodkey,et al. Signal Integration by Lipid-Mediated Spatial Cross Talk between Ras Nanoclusters , 2013, Molecular and Cellular Biology.
[43] A. Cox,et al. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif , 2015, Proceedings of the National Academy of Sciences.
[44] Tony Hunter,et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. , 2003, Cancer cell.
[45] Ruth Nussinov,et al. A New View of Ras Isoforms in Cancers. , 2016, Cancer research.
[46] Harikrishna Nakshatri,et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.
[47] A. Gorfe,et al. Ras nanoclusters: molecular structure and assembly. , 2007, Seminars in cell & developmental biology.
[48] B. Leber,et al. Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells , 2012, Cell.
[49] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[50] D. Abankwa,et al. Automated High-Throughput Fluorescence Lifetime Imaging Microscopy to Detect Protein–Protein Interactions , 2016, Journal of laboratory automation.
[51] Cord Naujokat,et al. Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.
[52] Sarah J. Plowman,et al. H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output , 2010, PloS one.
[53] Andrew M. Piggott,et al. Design and application of in vivo FRET biosensors to identify protein prenylation and nanoclustering inhibitors. , 2012, Chemistry & biology.
[54] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[55] J. Hancock,et al. Ras proteins: different signals from different locations , 2003, Nature Reviews Molecular Cell Biology.
[56] Rudolf Jaenisch,et al. Mechanisms and models of somatic cell reprogramming , 2013, Nature Reviews Genetics.
[57] Manjunath Hegde,et al. Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans , 2013, Stem Cell Research & Therapy.
[58] Angelo J. Canty,et al. Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.
[59] L. Joachimiak,et al. Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT. , 2014, European journal of medicinal chemistry.
[60] M. Endres,et al. Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice , 2014, Journal of Molecular Medicine.
[61] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[62] M. Kirkham,et al. PTRF-Cavin, a Conserved Cytoplasmic Protein Required for Caveola Formation and Function , 2008, Cell.
[63] Jeffrey A. Magee,et al. Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness , 2013, Nature.
[64] L. Reymond,et al. The Efficacy of Raf Kinase Recruitment to the GTPase H-ras Depends on H-ras Membrane Conformer-specific Nanoclustering*♦ , 2014, The Journal of Biological Chemistry.
[65] M. Parat,et al. Caveola-forming proteins caveolin-1 and PTRF in prostate cancer , 2013, Nature Reviews Urology.
[66] Eleonora Petrucci,et al. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. , 2010, Blood cells, molecules & diseases.
[67] Philipp M. Cromm,et al. Small-molecule modulation of Ras signaling. , 2014, Nature chemical biology.
[68] Ozlem Keskin,et al. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas , 2015, Molecular Cancer Research.
[69] P. Chatellard,et al. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. , 2001, Biotechnology and bioengineering.
[70] S. Ansieau. EMT in breast cancer stem cell generation. , 2013, Cancer letters.